Strategy to control methicillin-resistant Staphylococcus aureus post-operative infection in orthopaedic surgery.
In the year 2000 the rate of infection after arthroplasty in our hospital was 9.75% and methicillin-resistant Staphylococcus aureus (MRSA) was the organism in 33% of the infected joints. In an attempt to overcome this unacceptable situation, we changed our prophylaxis regime over a period of 6 months. This involved modifying the precautionary measures for preventing surgical infections, active prophylaxis against any nasal reservoir of infection in joint implant patients, the control of health care personnel, the strict application of standard and contact precautions in all patients with MRSA, and the use of teicoplanin as prophylaxis during this 6-month period. This resulted in a definite decrease in the incidence of orthopaedic wound infections by MRSA, while the level of MRSA infection elsewhere in the hospital remained constant. Only one infection was detected during this 6-month trial, and this beneficial effect was maintained during the following 6 months. Since then, only sporadic new infections have been detected. Patients with arthroplasties performed during the study were followed for 12 months, and no new cases of MRSA infection were detected.
Department of Orthopaedic Surgery, Fundacion Jimenez Diaz, Universidad Autonoma de Madrid, Avda Reyes Catolicos 2, 28040, Madrid, Spain.
J C
JC
De Lucas-Villarrubia
M
M
Lopez-Franco
J J
JJ
Granizo
J C
JC
De Lucas-Garcia
E
E
Gomez-Barrena
D019643:Arthroplasty, Replacement / Q000009:adverse effects*; D006801:Humans; D016106:Methicillin Resistance / Q000502:physiology; D013203:Staphylococcal Infections / Q000382:microbiology*; D013211:Staphylococcus aureus; D013530:Surgical Wound Infection / Q000382:microbiology* / Q000628:therapy; D016896:Treatment Outcome